AHA/ASA Issues Guidance for Optimal Stroke Care During COVID-19 Pandemic
AHA/ASA Stroke Council leadership published temporary emergency guidance for stroke management in the midst of COVID-19.
COVID19
FDA Authorizes Blood Purification System for COVID-19 Patients Admitted to ICU
The Agency believes that the ability to manage the cytokine storm associated with COVID-19 may decrease patient morbidity.
Cardiac Injury Common in Patients With COVID-19, Associated With Increased Mortality
Cardiac injury was found to be common in patients with coronavirus disease 2019 hospitalized at a single center in Wuhan, China medical center.
Sentinel Surveillance Can Help Monitor Epidemiology of COVID-19
Rapid sentinel surveillance can help monitor the epidemiology of coronavirus disease 2019 (COVID-19).
ACEI/ARB Treatment May Benefit Patients With COVID-19 and Hypertension
Treatment of patients with hypertension who are infected with the severe acute respiratory syndrome coronavirus 2 with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers may improve clinical outcomes.
FDA Issues Statement Regarding Tests for COVID-19 Antibodies
Serological tests allow for identification of individuals who have overcome COVID-19 infection.
Hydroxychloroquine Can Shorten Time to Recovery in COVID-19
Hydroxychloroquine (HCQ) can shorten time to clinical recovery and promote pneumonia absorption among patients with coronavirus disease 2019 (COVID-19).
Extracorporeal Membrane Oxygenation Might Aid in Severe Cases of COVID-19
Extracorporeal membrane oxygenation (ECMO) support might improve clinical outcomes in severe cases of coronavirus disease 2019 (COVID-19).
Joint Statement Issued on Reducing Arrhythmia Risk With COVID-19 Repurposed Drugs
Although not approved by the Food and Drug Administration (FDA) for COVID-19, hydroxychloroquine and azithromycin have been gaining momentum as potential treatments based on results of small studies.
ASHP: Critical Medications Needed for Ventilating Patients With COVID-19 in Short Supply
The ASHP warned that medications such as opioids, (eg, fentanyl, morphine, hydromorphone), sedatives (eg, midazolam, propofol), and paralytics (eg, pancuronium, rocuronium, succinylcholine), which must be administered concomitantly with mechanical ventilation, are already in or will likely be in shortage as the demand for these drugs to treat critically ill patients outpaces supply.
- Loading...
Loading...
Next post in Practice Management
Loading... 
Loading...